Widely used:Recently Viewed
Clear All$31.14
$-0.26
(-0.83%)
As on 30-Apr-2025 15:45EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$1,462 Mln
P/E Ratio
114.67
P/B Ratio
1.17
Industry P/E
--
Debt to Equity
0.3
ROE
0.01 %
ROCE
0.73 %
Div. Yield
0 %
Book Value
27.03
EPS
0.27
CFO
$1,097.22 Mln
EBITDA
$841.10 Mln
Net Profit
$276.87 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Omnicell Inc. ($0.001 par value) (OMCL)
| -30.05 | -11.05 | -30.32 | 13.65 | -34.17 | -15.99 | -1.46 |
|
BSE Sensex
| 2.55 | 3.65 | 4.54 | 7.46 | 12.04 | 19.65 | 11.41 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Omnicell Inc. ($0.001 par value) (OMCL)
| 18.15 | -25.37 | -72.06 | 50.34 | 46.87 | 33.44 | 26.11 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 12.89 | 10,202.62 | 12.01 | 12.69 | |
| 70.96 | 10,025.34 | 96.83 | 2.52 | |
| 159.82 | 8,863.93 | -- | -25.23 | |
| 288.68 | 11,513.99 | 277.87 | 3.65 |
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve... clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas. Address: 4220 North Freeway, Fort Worth, TX, United States, 76137 Read more
Founder, Executive Chairman, President & CEO
Mr. Randall A. Lipps
Founder, Executive Chairman, President & CEO
Mr. Randall A. Lipps
Headquarters
Fort Worth, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Omnicell Inc ($0001 par value) (OMCL) stood at $ 2,121 Mln as on 31-Dec-24
The share price of Omnicell Inc ($0001 par value) (OMCL) is $31.14 (NASDAQ) as of 30-Apr-2025 15:45 EDT. Omnicell Inc ($0001 par value) (OMCL) has given a return of -34.17% in the last 3 years.
Omnicell Inc ($0001 par value) (OMCL) has a market capitalisation of $ 1,462 Mln as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Omnicell Inc ($0001 par value) (OMCL) is 114.67 times as on 28-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Omnicell Inc ($0001 par value) (OMCL) and enter the required number of quantities and click on buy to purchase the shares of Omnicell Inc ($0001 par value) (OMCL).
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas. Address: 4220 North Freeway, Fort Worth, TX, United States, 76137
The CEO & director of Mr. Randall A. Lipps. is Omnicell Inc ($0001 par value) (OMCL), and CFO & Sr. VP is Mr. Randall A. Lipps.
There is no promoter pledging in Omnicell Inc ($0001 par value) (OMCL).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,078
|
|
|
1,054
|
|
|
964
|
|
|
853
|
| Omnicell Inc. ($0.001 par value) (OMCL) | Ratios |
|---|---|
|
Return on equity(%)
|
1.03
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
1.13
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Omnicell Inc ($0001 par value) (OMCL) was $0 Mln.
